BioHealth News Archive
Maryland Biotechnology Investment Incentive Tax Credit (BIITC) Program Still on but Delayed until mid-August
As a result of the ongoing COVID-19 pandemic and the impact on both government and business operations, under the authority of executive order, the…
Read More
Fina Biosolutions Awarded $289,000 from NIAID to Develop Carrier Protein for Conjugate Vaccines
Rockville, Maryland’s Fina Biosolutions recently was awarded an SBIR grant to develop a genetically detoxified tetanus toxin as a carrier protein for conjugate vaccines. The NIAID…
Read More
The importance of children’s hospitals during the COVID-19 pandemic | TheHill
Early reports of the COVID-19 pandemic, created an initial widespread impression that children were not severely affected by the virus. This understanding was framed…
Read More
Race for a Coronavirus Vaccine
About 48 hours after a Seattle woman received the first dose of an experimental vaccine against SARS-CoV-2, scientists in China—not to be outdone—announced that…
Read More
How a Johns Hopkins Professor and Her Chinese Students Tracked Coronavirus – WSJ
Lauren Gardner, an associate engineering professor at Johns Hopkins University, was sitting in a school coffee shop with two graduate students in January, chatting…
Read More
UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System | UM Ventures
BALTIMORE, May 7, 2020 /PRNewswire/ -- Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to Lyv, a cutting-edge clinical decision support system designed to help…
Read More
UM Ventures-Backed Breethe Acquired by Abiomed – University of Maryland, Baltimore
Last week, Abiomed acquired Baltimore-based startup Breethe for its innovative respiratory device. Breethe is a startup out of the University of Maryland, Baltimore (UMB) that…
Read More
Biobuzz Directory – Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage
Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans COLUMBIA, Md., May 4, 2020 Intralytix, Inc. announced today that…
Read More
Start-up hits $1 billion virtually as virus shifts Silicon Valley riches
When VAST Data hit the hallmark of this era’s Silicon Valley start-up boom last month, a $1 billion so-called unicorn valuation, it didn’t come…
Read More
The top pharma companies in social media | FiercePharma
Social media is no longer just a numbers game for pharma companies. Counting followers, tallying likes or tracking shares was a good start, but…
Read More
Emergent Biosolutions CEO: No ‘guarantee’ vaccine will be ready this year
Emergent Biosolutions CEO Robert Kramer told CNBC Monday it is uncertain that a coronavirus vaccine can be available by the end of the year to fulfill…
Read More
Immunomic Therapeutics Announces Appointments to its Board of Directors | Business & Finance | tullahomanews.com
ROCKVILLE, Md.--(BUSINESS WIRE)--May 5, 2020-- Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…
Read More
The SBA’s PPP: How to Prepare for a Potential Audit
Since the enactment of the CARES Act, the Small Business Administration and U.S. Department of the Treasury have continually updated the rules governing the…
Read More
BioHealth Innovation Entrepreneur-in-Residence Feedback Session – May 27th
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Sign up by…
Read More
Immunomic Therapeutics Founder and CEO Bill Hearl RETURNS to BioTalk after completing a new $61.3 million raise.
He joins BioTalk host Rich Bendis to discuss their recent successes in funding, research, and their growth in the BioHealth Capital Region Dr. William…
Read More